Skip to main content
Top
Published in: Diabetologia 4/2010

01-04-2010 | Article

Dimorphic histopathology of long-standing childhood-onset diabetes

Authors: R. Gianani, M. Campbell-Thompson, S. A. Sarkar, C. Wasserfall, A. Pugliese, J. M. Solis, S. C. Kent, B. J. Hering, E. West, A. Steck, S. Bonner-Weir, M. A. Atkinson, K. Coppieters, M. von Herrath, G. S. Eisenbarth

Published in: Diabetologia | Issue 4/2010

Login to get access

Abstract

Aims/hypothesis

Childhood diabetes is thought to usually result from autoimmune beta cell destruction (type 1A) with eventual total loss of beta cells. Analysis of C-peptide in children characterised at diabetes onset for autoantibodies shows heterogeneous preservation of insulin secretion in long-standing diabetes. The aim of this study was to characterise the pancreases of childhood-onset diabetes in order to define the pathological basis of this heterogeneity.

Methods

We evaluated 20 cadaveric organ donor pancreases of childhood-onset long-term patients for disease heterogeneity and obtained corresponding C-peptide measurements.

Results

Pancreases from the majority of cadaveric donors contained only insulin-deficient islets (14 of 20). The remaining six patients (30%) had numerous insulin-positive cells within at least some islets, with two different histological patterns. Pattern A (which we would associate with type 1A diabetes) had lobular retention of areas with ‘abnormal’ beta cells producing the apoptosis inhibitor survivin and HLA class I. In pattern B, 100% of all islets contained normal-appearing but quantitatively reduced beta cells without survivin or HLA class I.

Conclusions/interpretation

Our data demonstrate that C-peptide secretion in long-standing diabetic patients can be explained by two different patterns of beta cell survival, possibly reflecting different subsets of type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Spencer J, Peakman M (2009) Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell. Clin Exp Immunol 155:125–127CrossRefPubMed Spencer J, Peakman M (2009) Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell. Clin Exp Immunol 155:125–127CrossRefPubMed
2.
go back to reference Dotta F, Eisenbarth GS (1989) Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. Clin Immunol Immunopathol 50:85–95CrossRef Dotta F, Eisenbarth GS (1989) Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. Clin Immunol Immunopathol 50:85–95CrossRef
3.
4.
go back to reference Vaxillaire M, Bonnefond A, Froquel P (2009) Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. Pediatr Endocrinol Rev 6:405–417PubMed Vaxillaire M, Bonnefond A, Froquel P (2009) Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. Pediatr Endocrinol Rev 6:405–417PubMed
5.
go back to reference Maldonado M, Hampe CS, Gaur LK et al (2003) Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classsification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090–5098CrossRefPubMed Maldonado M, Hampe CS, Gaur LK et al (2003) Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classsification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090–5098CrossRefPubMed
6.
go back to reference Njolstad PR, Sovk O, Cuesta-Munoz A et al (2008) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588–1592CrossRef Njolstad PR, Sovk O, Cuesta-Munoz A et al (2008) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588–1592CrossRef
7.
go back to reference Wang J, Miao D, Babu S et al (2007) Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 92:88–92CrossRefPubMed Wang J, Miao D, Babu S et al (2007) Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 92:88–92CrossRefPubMed
8.
go back to reference Steck KA, Yu L, Armstrong T et al (2009) C-peptide levels correlate with age of onset, duration of diabetes and autoantibody status. Diabetes 58(Suppl 1):A459 (Abstract) Steck KA, Yu L, Armstrong T et al (2009) C-peptide levels correlate with age of onset, duration of diabetes and autoantibody status. Diabetes 58(Suppl 1):A459 (Abstract)
9.
go back to reference Foulis AK, Liddle CN, Farquharson JA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274CrossRefPubMed Foulis AK, Liddle CN, Farquharson JA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274CrossRefPubMed
10.
go back to reference Lohr M, Kloppel G (2004) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762 Lohr M, Kloppel G (2004) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762
11.
go back to reference Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed
12.
go back to reference Liggins C, Orlicky D, Bloomquist L, Gianani R (2008) Developmentally regulated expression of survivin in human pancreatic islets. Pediatr Dev Pathol 6:392–397CrossRef Liggins C, Orlicky D, Bloomquist L, Gianani R (2008) Developmentally regulated expression of survivin in human pancreatic islets. Pediatr Dev Pathol 6:392–397CrossRef
13.
go back to reference Hasel C, Bhanot UK, Maier R, Strater J, Moller P (2005) Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NF kappa B and IAPs. Lab Invest 85:1263–1275CrossRefPubMed Hasel C, Bhanot UK, Maier R, Strater J, Moller P (2005) Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NF kappa B and IAPs. Lab Invest 85:1263–1275CrossRefPubMed
14.
go back to reference Jiang Y, Nishimura W, Devor-Henneman D et al (2008) Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 57:2718–2727CrossRefPubMed Jiang Y, Nishimura W, Devor-Henneman D et al (2008) Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 57:2718–2727CrossRefPubMed
15.
go back to reference Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabets. PNAS 104:17040–17045CrossRefPubMed Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabets. PNAS 104:17040–17045CrossRefPubMed
16.
go back to reference Chen J, Munter P, Hamm LL et al (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 4:469–477CrossRef Chen J, Munter P, Hamm LL et al (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 4:469–477CrossRef
17.
18.
go back to reference Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308CrossRefPubMed Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308CrossRefPubMed
Metadata
Title
Dimorphic histopathology of long-standing childhood-onset diabetes
Authors
R. Gianani
M. Campbell-Thompson
S. A. Sarkar
C. Wasserfall
A. Pugliese
J. M. Solis
S. C. Kent
B. J. Hering
E. West
A. Steck
S. Bonner-Weir
M. A. Atkinson
K. Coppieters
M. von Herrath
G. S. Eisenbarth
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1642-y

Other articles of this Issue 4/2010

Diabetologia 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.